Acceleron Pharma (XLRN) Reports Planned Retirement of Dr. Matthew Sherman from Chief Medical Officer Position
Tweet Send to a Friend
Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the planned retirement of Executive Vice President and Chief Medical Officer Matthew L ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
